Byrne Asset Management LLC Sells 72 Shares of HCA Healthcare, Inc. (NYSE:HCA)

Byrne Asset Management LLC decreased its holdings in shares of HCA Healthcare, Inc. (NYSE:HCA) by 13.3% in the 4th quarter, according to its most recent Form 13F filing with the SEC. The firm owned 470 shares of the company’s stock after selling 72 shares during the period. Byrne Asset Management LLC’s holdings in HCA Healthcare were worth $141,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also recently modified their holdings of the business. Legacy Investment Solutions LLC purchased a new stake in shares of HCA Healthcare during the 3rd quarter valued at $39,000. Capital Performance Advisors LLP bought a new position in shares of HCA Healthcare during the 3rd quarter valued at about $41,000. Canoe Financial LP purchased a new stake in HCA Healthcare in the third quarter worth approximately $41,000. Northwest Investment Counselors LLC purchased a new stake in shares of HCA Healthcare in the 3rd quarter valued at $44,000. Finally, Friedenthal Financial bought a new stake in HCA Healthcare in the third quarter worth $50,000. Hedge funds and other institutional investors own 62.73% of the company’s stock.

Insider Activity

In other news, insider Erol R. Akdamar sold 2,900 shares of the company’s stock in a transaction dated Thursday, November 14th. The stock was sold at an average price of $353.00, for a total value of $1,023,700.00. Following the completion of the transaction, the insider now owns 6,843 shares of the company’s stock, valued at $2,415,579. This represents a 29.76 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, SVP Phillip G. Billington sold 3,897 shares of the company’s stock in a transaction that occurred on Thursday, November 14th. The stock was sold at an average price of $350.00, for a total value of $1,363,950.00. Following the completion of the transaction, the senior vice president now owns 52,702 shares of the company’s stock, valued at $18,445,700. The trade was a 6.89 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders own 1.70% of the company’s stock.

Wall Street Analyst Weigh In

Several equities research analysts recently weighed in on HCA shares. Wells Fargo & Company cut HCA Healthcare from an “equal weight” rating to an “underweight” rating and dropped their target price for the company from $400.00 to $320.00 in a report on Monday, November 25th. Royal Bank of Canada decreased their price objective on shares of HCA Healthcare from $405.00 to $384.00 and set an “outperform” rating on the stock in a research report on Monday, January 27th. Cantor Fitzgerald restated an “overweight” rating and set a $405.00 price target on shares of HCA Healthcare in a report on Monday, January 27th. TD Cowen decreased their target price on HCA Healthcare from $450.00 to $440.00 and set a “buy” rating for the company in a report on Monday, October 28th. Finally, Oppenheimer increased their target price on HCA Healthcare from $390.00 to $400.00 and gave the stock an “outperform” rating in a research report on Monday, October 28th. One investment analyst has rated the stock with a sell rating, three have assigned a hold rating, thirteen have assigned a buy rating and two have assigned a strong buy rating to the stock. According to MarketBeat, the company presently has an average rating of “Moderate Buy” and an average target price of $385.67.

HCA Healthcare Stock Down 0.8 %

Shares of HCA Healthcare stock opened at $321.95 on Friday. The company has a market cap of $81.55 billion, a price-to-earnings ratio of 14.65, a price-to-earnings-growth ratio of 1.13 and a beta of 1.64. The company has a quick ratio of 0.97, a current ratio of 1.08 and a debt-to-equity ratio of 69.07. The company’s 50 day moving average is $313.85 and its 200 day moving average is $353.37. HCA Healthcare, Inc. has a twelve month low of $289.98 and a twelve month high of $417.14.

HCA Healthcare (NYSE:HCA) last posted its earnings results on Friday, January 24th. The company reported $6.22 earnings per share for the quarter, beating analysts’ consensus estimates of $6.03 by $0.19. HCA Healthcare had a return on equity of 586.47% and a net margin of 8.16%. During the same period in the prior year, the business earned $5.90 EPS. Research analysts anticipate that HCA Healthcare, Inc. will post 24.89 EPS for the current year.

HCA Healthcare Increases Dividend

The company also recently announced a quarterly dividend, which will be paid on Monday, March 31st. Shareholders of record on Monday, March 17th will be paid a dividend of $0.72 per share. This is a boost from HCA Healthcare’s previous quarterly dividend of $0.66. The ex-dividend date of this dividend is Monday, March 17th. This represents a $2.88 dividend on an annualized basis and a yield of 0.89%. HCA Healthcare’s dividend payout ratio (DPR) is presently 12.02%.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.